Cancer breakthrough: could less surgery save faces and lives?
NCT ID NCT07320690
Summary
This study is testing whether patients with advanced head and neck cancer who respond well to initial immunotherapy can safely have less extensive surgery. The goal is to see if this 'de-escalated' surgery preserves more normal tissue and function—like speaking and swallowing—without lowering the 3-year survival rate compared to standard, more aggressive surgery. It will involve 356 patients at multiple hospitals.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Ninth Peolple's Hospital
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.